HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Ovarian failure — Clinical Guidelines

Overview

Premature ovarian failure (POF) is characterized by the cessation of ovarian function before age 40, leading to amenorrhea, infertility, and often hormonal imbalances such as amenorrhea and elevated gonadotropin levels. 1 2 3

Diagnosis

Amenorrhea for at least 3 consecutive cycles

Elevated follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels on at least two occasions 4 weeks apart

Low estradiol levels

Exclusion of other causes of secondary amenorrhea 2

Management

Hormone Replacement Therapy (HRT): Estrogen and progesterone to manage symptoms and prevent osteoporosis (specific doses not detailed) 2

Low-Intensity Pulsed Ultrasound (LIPUS): Emerging therapy for promoting ovarian function and tissue regeneration (specific protocols not detailed) 1

Ovarian Biopsy: Minilaparoscopic approach under conscious sedation can be feasible and effective compared to traditional laparoscopy for diagnostic purposes 4

Special Populations

Pregnancy: Cyclophosphamide use should be avoided in women with incomplete family planning due to risk of POF 2

Comorbidities: No specific pediatric or elderly considerations mentioned in the abstracts 3 4

Key Recommendations

Avoid cyclophosphamide in women with incomplete family planning to prevent premature ovarian failure (Evidence: Strong) 2

Consider low-intensity pulsed ultrasound as a potential adjunctive therapy for promoting ovarian function in POF (Evidence: Weak) 1

Minilaparoscopic ovarian biopsy under conscious sedation may be a feasible alternative to traditional laparoscopy for diagnostic procedures in POF (Evidence: Moderate) 4

References

1 Ji X, Duan H, Wang S, Chang Y. Low-intensity pulsed ultrasound in obstetrics and gynecology: advances in clinical application and research progress. Frontiers in endocrinology 2023. link 2 Saoji VA. Premature ovarian failure due to cyclophosphamide: a report of four cases in dermatology practice. Indian journal of dermatology, venereology and leprology 2008. link 3 Uda M, Ottolenghi C, Crisponi L, Garcia JE, Deiana M, Kimber W et al.. Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Human molecular genetics 2004. link 4 Pellicano M, Zullo F, Cappiello F, Di Carlo C, Cirillo D, Nappi C. Minilaparoscopic ovarian biopsy performed under conscious sedation in women with premature ovarian failure. The Journal of reproductive medicine 2000. link

Ovarian failure